Hält derzeit Positionen bei Oncopeptides AB and Gilead Sciences Inc
Position | Company | Period |
---|---|---|
Independent Chairman of the Board | Oncopeptides AB | 17. Mai 2018 - |
Independent Director | Gilead Sciences Inc | 28. Januar 2010 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-24 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
K Kauf |
204.664
2,60532.126 SEK |
204.664 | 2,60 | 532.126 SEK | |
2024-04-19 | 2024-04-19 |
Oncopeptides AB
(ONCO)
|
K Kauf |
204.664
2,60532.126 SEK |
204.664 | 2,60 | 532.126 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.000
27,1627.160 SEK |
1.000 | 27,16 | 27.160 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
250
27,136.783 SEK |
250 | 27,13 | 6.783 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
115
27,103.117 SEK |
115 | 27,10 | 3.117 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
500
27,0913.545 SEK |
500 | 27,09 | 13.545 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
480
26,9512.936 SEK |
480 | 26,95 | 12.936 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
176
26,954.743 SEK |
176 | 26,95 | 4.743 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
600
26,8916.134 SEK |
600 | 26,89 | 16.134 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
443
27,0011.961 SEK |
443 | 27,00 | 11.961 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
20
27,00540 SEK |
20 | 27,00 | 540 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
2.050
27,0055.350 SEK |
2.050 | 27,00 | 55.350 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.702
26,9445.852 SEK |
1.702 | 26,94 | 45.852 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.211
26,9332.612 SEK |
1.211 | 26,93 | 32.612 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
2.000
26,9253.840 SEK |
2.000 | 26,92 | 53.840 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.000
26,9126.910 SEK |
1.000 | 26,91 | 26.910 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
20
26,90538 SEK |
20 | 26,90 | 538 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.700
26,9045.730 SEK |
1.700 | 26,90 | 45.730 SEK | |
2022-08-31 | 2022-08-30 |
Oncopeptides AB
(ONCO)
|
K Kauf |
1.029
26,8927.670 SEK |
1.029 | 26,89 | 27.670 SEK | |
2022-01-12 | 2022-01-12 |
Oncopeptides AB
(ONCO)
|
K Kauf |
185.540
7,601.410.898 SEK |
185.540 | 7,60 | 1.410.898 SEK | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Verkauf |
6.600
-3.7%
35,08231.528 USD |
6.600 -3.7% | 35,08 | 231.528 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Verkauf |
3.600
-2.0%
35,05126.180 USD |
3.600 -2.0% | 35,05 | 126.180 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Verkauf |
24.800
-11.9%
35,03868.744 USD |
24.800 -11.9% | 35,03 | 868.744 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Verkauf |
35.000
-14.4%
35,011.225.350 USD |
35.000 -14.4% | 35,01 | 1.225.350 USD | |
2006-02-17 | 2006-02-16 |
Merck & Co Inc
(MRK)
|
V Verkauf |
24.949
-9.3%
35,00873.215 USD |
24.949 -9.3% | 35,00 | 873.215 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
7.500
-4.2%
45,19338.925 USD |
7.500 -4.2% | 45,19 | 338.925 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
5.000
-2.7%
45,18225.900 USD |
5.000 -2.7% | 45,18 | 225.900 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
15.000
-7.5%
45,13676.950 USD |
15.000 -7.5% | 45,13 | 676.950 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
7.500
-3.6%
45,10338.250 USD |
7.500 -3.6% | 45,10 | 338.250 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
5.000
-2.3%
45,04225.200 USD |
5.000 -2.3% | 45,04 | 225.200 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
16.400
-7.2%
45,03738.492 USD |
16.400 -7.2% | 45,03 | 738.492 USD | |
2004-08-04 | 2004-08-03 |
Merck & Co Inc
(MRK)
|
V Verkauf |
10.000
-4.2%
45,20452.000 USD |
10.000 -4.2% | 45,20 | 452.000 USD |